INNOVATIVE THERAPIES FOR SERIOUS DISEASES

Our mission is to develop meaningful therapies for patients with severe and life-threatening diseases that have been underserved by scientific innovation. We are investigating cellular and molecularly-targeted therapies with an initial focus on immunotherapy and oncology.

home

T-Cell
Product Candidates

EBV-CTL
CMV-CTL
WT1-CTL

More Information

Molecularly-Targeted
Product Candidates

STM 434

More Information

Latest News

RSS Feed Widget
View All Press Releases